FDA Approved: ANDEMBRY — Original Application (CSL)

View source ↗

Summary

The FDA approved ANDEMBRY (garadacimab) from CSL Behring under BLA761367, marking the first approval of this therapy. It is indicated for hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ANDEMBRY (garadacimab)

Snippet

ORIG AP for ANDEMBRY (GARADACIMAB)